CN114507710A - Biological material evidence collecting and preserving reagent - Google Patents
Biological material evidence collecting and preserving reagent Download PDFInfo
- Publication number
- CN114507710A CN114507710A CN202210162254.8A CN202210162254A CN114507710A CN 114507710 A CN114507710 A CN 114507710A CN 202210162254 A CN202210162254 A CN 202210162254A CN 114507710 A CN114507710 A CN 114507710A
- Authority
- CN
- China
- Prior art keywords
- reagent
- tris
- uric acid
- dna
- preservation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 59
- 239000012620 biological material Substances 0.000 title claims abstract description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000004321 preservation Methods 0.000 claims abstract description 18
- 239000007983 Tris buffer Substances 0.000 claims abstract description 15
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000001514 detection method Methods 0.000 claims abstract description 11
- NTDFJPCHHGBHCO-UHFFFAOYSA-N 7,9-dihydro-3H-purine-2,6,8-trione Chemical compound OC1=NC(O)=C2NC(O)=NC2=N1.N1C(=O)NC(=O)C2=C1NC(=O)N2 NTDFJPCHHGBHCO-UHFFFAOYSA-N 0.000 claims abstract description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract 8
- 229960001484 edetic acid Drugs 0.000 claims abstract 8
- 238000000034 method Methods 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000011324 bead Substances 0.000 claims description 5
- 238000001962 electrophoresis Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims 1
- 230000002906 microbiologic effect Effects 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 9
- 230000015556 catabolic process Effects 0.000 abstract description 7
- 238000006731 degradation reaction Methods 0.000 abstract description 7
- 229940116269 uric acid Drugs 0.000 abstract description 7
- 101710163270 Nuclease Proteins 0.000 abstract description 6
- 238000007400 DNA extraction Methods 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 12
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 150000002894 organic compounds Chemical class 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108091029865 Exogenous DNA Proteins 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 229940122426 Nuclease inhibitor Drugs 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000005202 decontamination Methods 0.000 description 2
- 230000003588 decontaminative effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000004144 purine metabolism Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- -1 wherein Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及法医物证DNA提取技术领域,具体地说是一种生物物证采集与保存试剂。The invention relates to the technical field of DNA extraction from forensic material evidence, in particular to a biological material evidence collection and preservation reagent.
背景技术Background technique
法医DNA技术在众多刑事案件的侦破、民事案件的解决、重大事故尸源的认定、被拐卖妇女儿童等人员的亲子鉴定上发挥了重要作用。随着法制建设的不断完善和DNA技术的不断发展,要求进行DNA检验的案件及物证也越来越多,法医DNA分析已然成为生物物证检验的常规技术。Forensic DNA technology has played an important role in the detection of many criminal cases, the settlement of civil cases, the identification of the source of corpses in major accidents, and the paternity testing of abducted women and children. With the continuous improvement of legal construction and the continuous development of DNA technology, more and more cases and physical evidences require DNA testing. Forensic DNA analysis has become a routine technology for biological evidence testing.
DNA是存在于生物体内的大分子,在离体的环境下,很容易被损坏、发生断裂,变成小分子,即DNA降解。成功的DNA分析始于生物物证检材的正确提取、保存与送检。来源于案件现场的法医生物检材承载着为侦查提供线索、为法庭提供证据的重要作用,检材的提取是否规范,保存是否妥当,送检是否及时都将直接影响到最终的鉴定结果。常规的生物检材有血液(斑)、唾液(斑)、精液(斑)、毛发、骨骼、脱落细胞等等,在这些生物检材中,脱落细胞类检材DNA含量低,加之在高温、潮湿的环境中DNA降解严重,影响DNA提取的质量和产量,易导致DNA分析失败。DNA is a macromolecule that exists in living organisms. In an in vitro environment, it is easy to be damaged, broken, and turned into small molecules, that is, DNA degradation. Successful DNA analysis begins with the correct extraction, preservation and submission of biological evidence materials. The forensic physical examination materials from the case scene play an important role in providing clues for the investigation and providing evidence for the court. Whether the extraction materials are standardized, whether they are properly stored, and whether they are submitted for inspection in a timely manner will directly affect the final identification result. Conventional biological samples include blood (spots), saliva (spots), semen (spots), hair, bones, exfoliated cells, etc. Among these biological samples, the DNA content of exfoliated cell-based samples is low. DNA is degraded seriously in a humid environment, affecting the quality and yield of DNA extraction, and easily leading to failure of DNA analysis.
《法医生物检材的提取、保存与送检规范(GA/T1162-2014)》为法医物证检验的检材提取、保存和送检制定了统一的规范要求,同时也为物证检验的成功提供了保障。对于采用擦拭方法提取的斑迹类检材,常采用干湿两步法提取,即先用湿润棉签擦拭检材客体表面,再用干燥棉签拭干转移。最常用的湿润棉签的试剂是去离子水,但有研究表明,去离子水擦拭提取的生物检材容易受微生物的作用而腐败,导致其中微量的DNA降解。目前,市面上已有专家学者在去离子水中加入抗生素用作脱落细胞采集试剂,这种方式能够有效抑制微生物对DNA破坏作用,但也有局限性,如不能很好的将脱落细胞与检材剥离等等。"Specifications for the Extraction, Preservation and Submission of Forensic Physical Examination Materials (GA/T1162-2014)" formulates unified standard requirements for the extraction, preservation and submission of forensic physical evidence examination materials, and also provides a basis for the success of physical evidence examination. Assure. For the stained samples extracted by the wiping method, the dry and wet two-step method is often used for extraction, that is, first wipe the surface of the sample object with a wet cotton swab, and then use a dry cotton swab to dry and transfer. The most commonly used reagent for moistening cotton swabs is deionized water, but studies have shown that biological samples extracted by wiping with deionized water are easily corrupted by microorganisms, resulting in the degradation of trace amounts of DNA. At present, experts and scholars on the market have added antibiotics to deionized water as exfoliated cell collection reagents. This method can effectively inhibit the damage of microorganisms to DNA, but it also has limitations, such as the inability to strip exfoliated cells from the specimen and many more.
因此,亟需开发一种生物物证采集与保存试剂,该试剂能够有效采集微量生物物证DNA,并提供避免DNA降解的微环境。Therefore, there is an urgent need to develop a biological evidence collection and preservation reagent, which can effectively collect trace amounts of biological evidence DNA and provide a microenvironment that avoids DNA degradation.
发明内容SUMMARY OF THE INVENTION
针对上述存在的问题,本发明的目的在于提供了一种生物物证采集与保存试剂。本发明试剂能有效采集微量生物物证DNA,并提供避免DNA降解的微环境。本发明试剂可以取代传统去离子水,用于干湿两步法擦拭提取斑痕类生物检材,实现DNA提取现场化,在法医领域具有广阔的发展前景。In view of the above problems, the purpose of the present invention is to provide a biological evidence collection and preservation reagent. The reagent of the invention can effectively collect trace amounts of biological evidence DNA and provide a microenvironment for avoiding DNA degradation. The reagent of the invention can replace the traditional deionized water, and can be used for wiping and extracting the stain-like biological test material by dry and wet two-step method, realizing the on-site DNA extraction, and has broad development prospects in the field of forensics.
本发明为实现上述目的,采取以下技术方案予以实现:The present invention adopts the following technical solutions to realize the above-mentioned purpose:
一种生物物证采集与保存试剂,所述试剂包括十二烷基磺酸钠(SDS)、乙二胺四乙酸(EDTA)、三羟甲基氨基甲烷(Tris)和尿酸(Uric acid);所述试剂中:所述十二烷基磺酸钠(SDS)的质量浓度为10%,所述乙二胺四乙酸(EDTA)的摩尔浓度为0.5mol/L,所述三羟甲基氨基甲烷(Tris)的摩尔浓度为1mol/L,所述尿酸(Uric acid)的摩尔浓度为2mol/L。A biological evidence collection and preservation reagent comprising sodium dodecyl sulfonate (SDS), ethylenediaminetetraacetic acid (EDTA), tris (Tris) and uric acid (Uric acid); Among the reagents: the mass concentration of the sodium dodecyl sulfonate (SDS) is 10%, the molar concentration of the ethylenediaminetetraacetic acid (EDTA) is 0.5mol/L, the tris(hydroxymethylaminomethane) The molar concentration of (Tris) is 1 mol/L, and the molar concentration of the uric acid (Uric acid) is 2 mol/L.
优选地,所述试剂的pH值调至8.0。Preferably, the pH of the reagent is adjusted to 8.0.
优选地,所述试剂用于微量生物物证采集与保存前须经分装、密封、灭菌和无核酸处理,具体如下:将pH值调至8.0的试剂分装到无核酸试剂瓶中,密封,经高压蒸汽灭菌处理后,取适量试剂经磁珠法提取DNA,并采用试剂盒扩增,电泳检测STR分型,未检出则为合格。Preferably, the reagents must be subpackaged, sealed, sterilized, and nucleic acid-free before being used for the collection and preservation of trace biological evidence. The details are as follows: the reagents whose pH value is adjusted to 8.0 are subpackaged into nucleic acid-free reagent bottles and sealed. , after high pressure steam sterilization, take appropriate amount of reagent to extract DNA by magnetic bead method, and use kit to amplify, and electrophoresis to detect STR typing, if not detected, it is qualified.
优选地,所述高压蒸汽灭菌处理具体如下:温度121.3℃,压力103.4kPa,时间20min。Preferably, the high-pressure steam sterilization treatment is as follows: the temperature is 121.3° C., the pressure is 103.4 kPa, and the time is 20 minutes.
优选地,所述适量试剂为100μl。Preferably, the appropriate amount of reagent is 100 μl.
本发明试剂为(SDS-EDTA-Tris-尿酸)四联试剂,其中,十二烷基磺酸钠(SDS)属阴离子表面活性剂,具有优异的渗透、洗涤、润湿、去污和乳化作用,易溶于水、乙醇,特殊的化学结构能够与细胞膜磷脂双分子层相似相溶,因而能够破坏细胞膜,将其中的DNA释放。乙二胺四乙酸(EDTA),是一种有机化合物,能与Mg2+、Ca2+、Mn2+、Fe2+等二价金属离子结合,常用作金属离子螯合剂,由于绝大多数核酸酶的活性中心需要Mg2+,用于核酸酶抑制剂,可以抑制核酸酶对DNA的破坏。三羟甲基氨基甲烷(Tris),是一种有机化合物,广泛应用于生物化学和分子生物学实验中缓冲液的制备,用于核酸的溶解。尿酸(Uric acid),是嘌呤代谢的终产物,为三氧基嘌呤,微溶于水,其化学性质稳定,易形成晶体,包裹DNA免受微生物侵染。The reagent of the present invention is (SDS-EDTA-Tris-uric acid) quadruple reagent, wherein, sodium dodecyl sulfonate (SDS) is an anionic surfactant and has excellent penetration, washing, wetting, decontamination and emulsifying effects , easily soluble in water and ethanol, and its special chemical structure can be similar to the cell membrane phospholipid bilayer, so it can destroy the cell membrane and release the DNA in it. Ethylenediaminetetraacetic acid (EDTA) is an organic compound that can combine with divalent metal ions such as Mg 2+ , Ca 2+ , Mn 2+ , Fe 2+ , and is often used as a metal ion chelating agent. The active center of nuclease requires Mg 2+ , which is used as a nuclease inhibitor, which can inhibit the damage of nuclease to DNA. Tris (Tris), an organic compound, is widely used in the preparation of buffers in biochemical and molecular biology experiments for the dissolution of nucleic acids. Uric acid, the final product of purine metabolism, is trioxypurine, slightly soluble in water, and its chemical properties are stable, easy to form crystals, and encapsulate DNA to prevent microbial infection.
与现有技术相比,本发明的有益效果如下:Compared with the prior art, the beneficial effects of the present invention are as follows:
本发明试剂联合四种成分(SDS-EDTA-Tris-尿酸),互相配合、协作,使得试剂能够有利于微量细胞从生物物证上剥离,能够有效抑制核酸酶对DNA的破坏,能够提供避免DNA降解的微环境。The reagent of the present invention combines four components (SDS-EDTA-Tris-uric acid) to cooperate and cooperate with each other, so that the reagent can facilitate the stripping of trace cells from biological evidence, can effectively inhibit the damage of nuclease to DNA, and can provide protection against DNA degradation. microenvironment.
本发明试剂在室温下(25℃)保质期达1年以上,无外源DNA污染,无毒害作用,不影响实验室后续DNA检测。The reagent of the invention has a shelf life of more than 1 year at room temperature (25° C.), has no contamination by exogenous DNA, has no toxic effect, and does not affect subsequent DNA detection in the laboratory.
采用指纹印痕模拟犯罪现场脱落细胞,本发明试剂与去离子水进行对比实验,本发明试剂检出率高;10μl经100倍稀释血液细胞采集后干燥,室温保存1年,本发明试剂检出率高。Fingerprint imprints are used to simulate exfoliated cells at the crime scene. The reagent of the invention is compared with deionized water. The detection rate of the reagent of the invention is high. high.
本发明试剂中各个化学组分可全部国产化,且价格便宜,无毒无害,环境友好,广泛推广能够大大提高生物检材检出率,具有良好的社会、经济效益。All chemical components in the reagent of the invention can be domestically produced, and the reagent is cheap, non-toxic and harmless, and environmentally friendly.
附图说明Description of drawings
图1是实施例4中用实施例2处理后合格的试剂采集模拟检材得到的DNA分型图谱;Fig. 1 is the DNA genotyping map obtained by collecting simulated samples with qualified reagents after being processed in Example 2 in Example 4;
图2是实施例4中用去离子水采集模拟检材得到的DNA分型图谱。FIG. 2 is a DNA typing pattern obtained by collecting simulated samples with deionized water in Example 4. FIG.
具体实施方式Detailed ways
为更好的说明本发明的目的、技术方案和优点,下面将结合具体实施例对本发明作进一步说明。In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below with reference to specific embodiments.
实施例1Example 1
一种生物物证采集与保存试剂的配置,该试剂包括十二烷基磺酸钠(SDS)、乙二胺四乙酸(EDTA)、三羟甲基氨基甲烷(Tris)和尿酸(Uric acid)。该试剂中:十二烷基磺酸钠(SDS)的质量浓度为10%,乙二胺四乙酸(EDTA)的摩尔浓度为0.5mol/L,三羟甲基氨基甲烷(Tris)的摩尔浓度为1mol/L,尿酸(Uric acid)的摩尔浓度为2mol/L。A configuration of a biological evidence collection and preservation reagent, the reagent includes sodium dodecyl sulfonate (SDS), ethylenediaminetetraacetic acid (EDTA), tris (Tris) and uric acid (Uric acid). In this reagent: the mass concentration of sodium dodecyl sulfonate (SDS) is 10%, the molar concentration of ethylenediaminetetraacetic acid (EDTA) is 0.5mol/L, and the molar concentration of tris (Tris) is 1 mol/L, and the molar concentration of uric acid is 2 mol/L.
本发明试剂为(SDS-EDTA-Tris-尿酸)四联试剂,其中,十二烷基磺酸钠(SDS)属阴离子表面活性剂,具有优异的渗透、洗涤、润湿、去污和乳化作用,易溶于水、乙醇,特殊的化学结构能够与细胞膜磷脂双分子层相似相溶,因而能够破坏细胞膜,将其中的DNA释放。乙二胺四乙酸(EDTA),是一种有机化合物,能与Mg2+、Ca2+、Mn2+、Fe2+等二价金属离子结合,常用作金属离子螯合剂,由于绝大多数核酸酶的活性中心需要Mg2+,用于核酸酶抑制剂,可以抑制核酸酶对DNA的破坏。三羟甲基氨基甲烷(Tris),是一种有机化合物,广泛应用于生物化学和分子生物学实验中缓冲液的制备,用于核酸的溶解。尿酸(Uric acid),是嘌呤代谢的终产物,为三氧基嘌呤,微溶于水,其化学性质稳定,易形成晶体,包裹DNA免受微生物侵染。The reagent of the present invention is (SDS-EDTA-Tris-uric acid) quadruple reagent, wherein, sodium dodecyl sulfonate (SDS) is an anionic surfactant and has excellent penetration, washing, wetting, decontamination and emulsifying effects , easily soluble in water and ethanol, and its special chemical structure can be similar to the cell membrane phospholipid bilayer, so it can destroy the cell membrane and release the DNA in it. Ethylenediaminetetraacetic acid (EDTA) is an organic compound that can combine with divalent metal ions such as Mg 2+ , Ca 2+ , Mn 2+ , Fe 2+ , and is often used as a metal ion chelating agent. The active center of nuclease requires Mg 2+ , which is used as a nuclease inhibitor, which can inhibit the damage of nuclease to DNA. Tris, an organic compound, is widely used in the preparation of buffers in biochemical and molecular biology experiments for the dissolution of nucleic acids. Uric acid, the final product of purine metabolism, is trioxypurine, slightly soluble in water, and its chemical properties are stable, easy to form crystals, and encapsulate DNA to prevent microbial infection.
实施例2Example 2
一种生物物证采集与保存试剂(如实施例1所述)的分装、密封、灭菌和无核酸处理,具体如下:将pH值调至8.0的试剂分装到无核酸试剂瓶中,密封,经高压蒸汽灭菌处理(温度121.3℃,压力103.4kPa,时间20min)后,取100μl试剂经磁珠法提取DNA,并采用试剂盒扩增,电泳检测STR分型,未检出则为合格。The sub-packaging, sealing, sterilization and nucleic acid-free treatment of a biological evidence collection and preservation reagent (as described in Example 1) are as follows: the reagent whose pH value is adjusted to 8.0 is distributed into a nucleic acid-free reagent bottle, sealed , after high pressure steam sterilization (temperature 121.3°C, pressure 103.4kPa, time 20min), take 100μl of reagent to extract DNA by magnetic bead method, and use the kit to amplify, detect STR typing by electrophoresis, if not detected, it is qualified .
实施例3Example 3
采用指纹印痕模拟犯罪现场脱落细胞,将实施例2处理后合格的试剂与去离子水进行对比实验。分别采集90枚指纹脱落细胞后,经磁珠法提取DNA,并采用试剂盒扩增,电泳检测STR分型,本实验采用大于100个荧光单位进行判读,低于此标准不进行统计,计算两组实验DNA位点检出率:Fingerprint imprints were used to simulate the exfoliated cells at the crime scene, and a comparative experiment was conducted between the qualified reagents treated in Example 2 and deionized water. After collecting 90 fingerprint exfoliated cells, DNA was extracted by magnetic bead method, amplified by kit, and STR typing was detected by electrophoresis. In this experiment, more than 100 fluorescence units were used for interpretation. The detection rate of DNA loci in the group experiment:
实施例2处理后合格的试剂采集90枚指纹,DNA位点检出率为:76.9%。In Example 2, 90 fingerprints were collected from qualified reagents after treatment, and the detection rate of DNA loci was: 76.9%.
去离子水采集90枚指纹,DNA位点检出率为:42.9%。Deionized water was used to collect 90 fingerprints, and the detection rate of DNA loci was 42.9%.
实施例4Example 4
采用稀释血模拟犯罪现场微量生物检材,将实施例2处理后合格的试剂与去离子水进行对比实验,分别采集90份模拟检材后,室温(25±2℃)下放置1年,经磁珠法提取DNA,并采用试剂盒扩增,电泳检测STR分型,本实验采用大于100个荧光单位进行判读,低于此标准不进行统计,计算两组实验DNA位点检出率:Diluted blood was used to simulate the trace biological samples at the crime scene, and the qualified reagents treated in Example 2 were compared with deionized water. DNA was extracted by magnetic bead method, amplified by kit, and STR typing was detected by electrophoresis. In this experiment, more than 100 fluorescence units were used for interpretation, and statistics were not performed below this standard. The detection rate of DNA loci in the two groups of experiments was calculated:
实施例2处理后合格的试剂采集90份模拟检材,DNA位点检出率为:100%,且所有样本分型杂合子均衡度好;图1是用实施例2处理后合格的试剂采集模拟检材得到的DNA分型图谱。90 mock samples were collected with qualified reagents after the treatment in Example 2. The detection rate of DNA loci was 100%, and the heterozygotes of all samples were well balanced; Figure 1 is the collection of qualified reagents after treatment with Example 2. The DNA typing map obtained from the simulated samples.
去离子水采集90枚模拟检材,DNA位点检出率为95.2%,且所有样本分型均呈现长片段降解趋势,图2是用去离子水采集模拟检材得到的DNA分型图谱。90 samples were collected in deionized water, and the detection rate of DNA loci was 95.2%, and all samples showed a trend of long fragment degradation.
实施例5Example 5
将实施例2处理后合格的试剂置于室温下(25℃)保存,考察保存时间的影响:The qualified reagents treated in Example 2 were placed at room temperature (25° C.) for preservation, and the influence of the preservation time was investigated:
由上表可知:本发明试剂在室温下(25℃)保质期达1年以上,无外源DNA污染,无毒害作用,不影响实验室DNA检验,符合法医物证检验标准要求,技术水平可达到国际先进水平。It can be seen from the above table that the reagent of the present invention has a shelf life of more than 1 year at room temperature (25° C.), has no exogenous DNA pollution, has no toxic effect, does not affect laboratory DNA testing, meets the requirements of forensic material evidence testing standards, and its technical level can reach international standards. advanced level.
以上对本发明实施例所提供的技术方案进行了详细介绍,本文中应用了具体个例对本发明实施例的原理以及实施方式进行了阐述,以上实施例的说明只适用于帮助理解本发明实施例的原理;同时,对于本领域的一般技术人员,依据本发明实施例,在具体实施方式以及应用范围上均会有改变之处,综上所述,本说明书内容不应理解为对本发明的限制。The technical solutions provided by the embodiments of the present invention have been described in detail above. The principles and implementations of the embodiments of the present invention are described in this paper by using specific examples. The descriptions of the above embodiments are only applicable to help understand the embodiments of the present invention. At the same time, for those of ordinary skill in the art, according to the embodiments of the present invention, there will be changes in the specific implementation and application scope. To sum up, the contents of this specification should not be construed as limitations of the present invention.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210162254.8A CN114507710A (en) | 2022-02-22 | 2022-02-22 | Biological material evidence collecting and preserving reagent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210162254.8A CN114507710A (en) | 2022-02-22 | 2022-02-22 | Biological material evidence collecting and preserving reagent |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114507710A true CN114507710A (en) | 2022-05-17 |
Family
ID=81553243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210162254.8A Pending CN114507710A (en) | 2022-02-22 | 2022-02-22 | Biological material evidence collecting and preserving reagent |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114507710A (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756126A (en) * | 1991-05-29 | 1998-05-26 | Flinders Technologies Pty. Ltd. | Dry solid medium for storage and analysis of genetic material |
US5807527A (en) * | 1991-05-29 | 1998-09-15 | Flinders Technologies Pty. Ltd. | Solid medium and method for DNA storage |
US5972386A (en) * | 1995-12-19 | 1999-10-26 | Flinders Technologies Pty, Ltd. | Dry solid medium for storage and analysis of genetic material |
US20040101895A1 (en) * | 1999-04-14 | 2004-05-27 | Galina Fomovskaia | Fta-coated media for use as a molecular diagnostic tool |
US20060094015A1 (en) * | 2002-10-04 | 2006-05-04 | Whatman Inc. | Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems |
CN101048501A (en) * | 2004-09-07 | 2007-10-03 | 固德基因公司 | Method for storing DNA by using chitosan, and products using the methods |
CN101153263A (en) * | 2007-09-07 | 2008-04-02 | 鼎生科技(北京)有限公司 | Blood DNA conserving card and method for making the same |
CN106029910A (en) * | 2014-02-28 | 2016-10-12 | 通用电气医疗集团英国有限公司 | Storage of processed biological samples and improvements related thereto |
CN112322697A (en) * | 2020-11-09 | 2021-02-05 | 苏州乾康基因有限公司 | DNA sample preservation solution and preparation method and application thereof |
-
2022
- 2022-02-22 CN CN202210162254.8A patent/CN114507710A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756126A (en) * | 1991-05-29 | 1998-05-26 | Flinders Technologies Pty. Ltd. | Dry solid medium for storage and analysis of genetic material |
US5807527A (en) * | 1991-05-29 | 1998-09-15 | Flinders Technologies Pty. Ltd. | Solid medium and method for DNA storage |
US5972386A (en) * | 1995-12-19 | 1999-10-26 | Flinders Technologies Pty, Ltd. | Dry solid medium for storage and analysis of genetic material |
US20040101895A1 (en) * | 1999-04-14 | 2004-05-27 | Galina Fomovskaia | Fta-coated media for use as a molecular diagnostic tool |
US20060094015A1 (en) * | 2002-10-04 | 2006-05-04 | Whatman Inc. | Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems |
CN101048501A (en) * | 2004-09-07 | 2007-10-03 | 固德基因公司 | Method for storing DNA by using chitosan, and products using the methods |
CN101153263A (en) * | 2007-09-07 | 2008-04-02 | 鼎生科技(北京)有限公司 | Blood DNA conserving card and method for making the same |
CN106029910A (en) * | 2014-02-28 | 2016-10-12 | 通用电气医疗集团英国有限公司 | Storage of processed biological samples and improvements related thereto |
CN112322697A (en) * | 2020-11-09 | 2021-02-05 | 苏州乾康基因有限公司 | DNA sample preservation solution and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101153263B (en) | Blood DNA conserving card and method for making the same | |
CN112322697A (en) | DNA sample preservation solution and preparation method and application thereof | |
CN104651524A (en) | Method for storing biological samples and kit | |
CN110982876A (en) | Pretreatment method, pretreatment liquid, kit and application of virus nucleic acid detection | |
CN107509722B (en) | Specimen preservation solution | |
CN103789202A (en) | Container for collecting nucleic acid preserved at normal temperature | |
CN106867998A (en) | The kit of pathogen nucleic acid is extracted in the high throughput automated sample from sputum | |
CN111378719B (en) | Reagent compositions and methods for preserving nucleic acid integrity in human saliva | |
CN108949748B (en) | Sputum liquefaction and nucleic acid protection reagent | |
Pandiar et al. | Use of jaggery and honey as adjunctive cytological fixatives to ethanol for oral smears | |
CN110352950A (en) | One kind having the non-cervical exfoliated cell preservative fluid of preprocessing function and application | |
CN114568423A (en) | Preparation and application of multipurpose novel cell preservation solution | |
CN112608978A (en) | Novel nucleic acid hand-free storage solution | |
CN114507710A (en) | Biological material evidence collecting and preserving reagent | |
CN112400861B (en) | Cell preservation solution for rapid cell immunohistochemistry and preparation method and application thereof | |
CN107904152B (en) | Sputum collecting pipe for nucleic acid detection and sputum preservation method | |
CN113999840B (en) | Nucleic acid sample preservation solution and use method and application thereof | |
CN114675017A (en) | A kind of biological sample extract and its application and using method | |
CN111961664A (en) | Nucleic acid extracting solution | |
CN116355893B (en) | Magnetic bead method nucleic acid extraction kit and application thereof | |
CN103134844B (en) | A kind of being used for screens and evaluates the genotoxic method of complicated ingredient industrial waste water | |
CN111876330B (en) | Virus transport culture medium suitable for nucleic acid detection and preparation method thereof | |
CN116508744A (en) | Sample preservation solution for detecting novel coronavirus antigen and preparation method thereof | |
CN106350510A (en) | Method and kit for quickly extracting genome DNA from forest frog's oviduct, and application thereof | |
CN119061004B (en) | Microbial flora nucleic acid DNA preservation solution for sputum sample |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220517 |